<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01191788</url>
  </required_header>
  <id_info>
    <org_study_id>R01AA014699-03</org_study_id>
    <secondary_id>R01AA014699</secondary_id>
    <nct_id>NCT01191788</nct_id>
  </id_info>
  <brief_title>Building Recovery By Improving Goals, Habits, and Thoughts</brief_title>
  <acronym>BRIGHT</acronym>
  <official_title>Group Cognitive Behavioral Therapy (CBT) For Depression in Clients With Alcohol and Other Drug (AOD) Disorders</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RAND</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Behavioral Health Services, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>RAND</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators will investigate whether group Cognitive Behavioral Therapy (CBT) for
      depression, with alcohol and other drug (AOD) treatment counselors leading the groups, is
      effective and cost effective in treating depression. If so, it could substantially increase
      access to appropriate mental health care. 360 clients with Beck Depression Inventory-II
      scores &gt; 17 who are being treated in a single public sector AOD treatment organization will
      receive one of two conditions: (1) usual care residential AOD treatment (UC); (2) usual care
      AOD residential treatment plus a 16-session course of group CBT delivered by trained AOD
      counselors (CBT). Data will be analyzed using an intent-to-treat model. The investigators
      will collect data on the service-level costs and health effects associated with UC and CBT,
      and will calculate the incremental cost per unit of depression and AOD improvement, compared
      to UC.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Individuals with alcohol and other drug (AOD) disorders frequently suffer from depression,
      leading to reduced quality of life and poorer AOD treatment outcomes. Efficacious treatments
      for depression do exist and could improve outcomes; but national data suggest that fewer than
      7% of people with co-occurring disorders who are in AOD treatment have received appropriate
      treatment. Group cognitive behavioral therapy (CBT) is an effective and inexpensive treatment
      for depression. We propose to investigate whether group CBT for depression, with AOD
      counselors leading the groups, is effective and cost effective in treating depression. If so,
      it could substantially increase access to appropriate mental health care.

      We propose a 5-year quasi-experimental study with the following specific aims: Aim 1. To
      evaluate the effectiveness of group CBT for depression provided by AOD counselors in
      improving depressive symptoms and AOD outcomes, among clients being treated in public sector
      residential AOD treatment settings; Aim 2. To evaluate the cost-effectiveness of group CBT
      conducted by trained AOD counselors compared to usual care AOD treatment; Aim 3. To document
      the implementation of the intervention at each of the four sites, and to determine whether
      the AOD counselors are delivering the group CBT intervention with fidelity to the model, and
      whether treatment fidelity is a significant predictor of client outcomes.

      We will enroll and follow 360 clients with Beck Depression Inventory-II (BDI-II) scores &gt; 17
      who are being treated in a single public sector AOD treatment organization at four
      residential sites in LA County. Subjects will receive one of two conditions: (1) usual care
      residential AOD treatment (UC); (2) usual care AOD residential treatment plus a 16-session
      course of group CBT delivered by trained AOD counselors (CBT). Subjects will complete: (1) a
      baseline interview; (2) a post-treatment interview (at the conclusion of the CBT treatment)
      and (3) a follow-up interview (3 months after CBT treatment ends). Data will be analyzed
      using an intent-to-treat model. We will collect data on the service-level costs and health
      effects associated with UC and CBT, and will calculate the incremental cost per unit of
      depression and AOD improvement, compared to UC. . The implementation analysis will involve
      two related sets of activities: (1) a series of key informant interviews to provide a context
      in which to understand intervention implementation and (2) an assessment of treatment
      fidelity and it's relationship to client outcomes.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2006</start_date>
  <completion_date type="Actual">March 2010</completion_date>
  <primary_completion_date type="Actual">July 2009</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Depressive Symptoms as Measured by the Beck Depression Inventory II</measure>
    <time_frame>3 Months Post Treatment</time_frame>
    <description>The Beck Depression Inventory II (BDI-II) is a 21 question, self-administered measure of depressive symptoms. Scores range from 0 - 63, with higher scores indicating more severe depressive symptoms.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mental Health Functioning as Measured by SF-12 MCS.</measure>
    <time_frame>3 Months Post Treatment</time_frame>
    <description>The SF-12 is a 12 question, self-administered measure of general health functioning. The SF-12 outputs a mental health summary score (MCS), which ranges from 0 to 100, with higher scores indicating better mental health functioning. MCS scores are standardized such that mean = 50 and SD = 10 in the general U.S. population.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">299</enrollment>
  <condition>Depression</condition>
  <condition>Substance Use</condition>
  <arm_group>
    <arm_group_label>Group CBT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Clients received up to 16 sessions of group CBT for depression</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Comparison</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Treatment as Usual comparison condition</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Group Cognitive Behavioral Therapy</intervention_name>
    <description>16 two hour sessions of group CBT</description>
    <arm_group_label>Group CBT</arm_group_label>
    <arm_group_label>Comparison</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Group CBT for Depression</intervention_name>
    <description>16 of group CBT for depression delivered in 2 hour groups for up to 8 weeks by a trained substance abuse treatment counselor</description>
    <arm_group_label>Group CBT</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  present for treatment at one of four participating sites during study period

          -  score BDI&gt;17 at 2-4 weeks post-treatment entry

        Exclusion Criteria:

          -  cognitive impairment (score of 11 or greater on short Blessed exam)

          -  screen positive for bipolar or schizophrenia

          -  non-English speaker
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Katherine Watkins, MD, MSHS</last_name>
    <role>Principal Investigator</role>
    <affiliation>RAND</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Behavioral Health Services, Inc</name>
      <address>
        <city>Gardena</city>
        <state>California</state>
        <zip>90249</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.rand.org/health/projects/bright/</url>
    <description>Project BRIGHT Manuals</description>
  </link>
  <link>
    <url>http://www.rand.org/health/projects/bright/publications.html</url>
    <description>Project BRIGHT Brochure</description>
  </link>
  <verification_date>May 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 29, 2010</study_first_submitted>
  <study_first_submitted_qc>August 30, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 31, 2010</study_first_posted>
  <results_first_submitted>October 24, 2011</results_first_submitted>
  <results_first_submitted_qc>May 22, 2012</results_first_submitted_qc>
  <results_first_posted type="Estimate">June 25, 2012</results_first_posted>
  <last_update_submitted>May 22, 2012</last_update_submitted>
  <last_update_submitted_qc>May 22, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 25, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Depression</keyword>
  <keyword>Substance Use</keyword>
  <keyword>Group Cognitive Behavioral Therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Group CBT</title>
          <description>Clients received up to 16 sessions of group CBT for depression</description>
        </group>
        <group group_id="P2">
          <title>Comparison</title>
          <description>Treatment as Usual comparison condition</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="140"/>
                <participants group_id="P2" count="159"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="119">Completed 3-month followup</participants>
                <participants group_id="P2" count="137">Completed 3-month followup</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
                <participants group_id="P2" count="22"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
                <participants group_id="P2" count="22"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Group CBT</title>
          <description>Clients received up to 16 sessions of group CBT for depression</description>
        </group>
        <group group_id="B2">
          <title>Comparison</title>
          <description>Treatment as Usual comparison condition</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="140"/>
            <count group_id="B2" value="159"/>
            <count group_id="B3" value="299"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="139"/>
                    <measurement group_id="B2" value="159"/>
                    <measurement group_id="B3" value="298"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="35.31" spread="10.08"/>
                    <measurement group_id="B2" value="37.04" spread="10.53"/>
                    <measurement group_id="B3" value="36.23" spread="10.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="70"/>
                    <measurement group_id="B2" value="74"/>
                    <measurement group_id="B3" value="144"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="70"/>
                    <measurement group_id="B2" value="85"/>
                    <measurement group_id="B3" value="155"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="140"/>
                    <measurement group_id="B2" value="159"/>
                    <measurement group_id="B3" value="299"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Depressive Symptoms as Measured by the Beck Depression Inventory II</title>
        <description>The Beck Depression Inventory II (BDI-II) is a 21 question, self-administered measure of depressive symptoms. Scores range from 0 - 63, with higher scores indicating more severe depressive symptoms.</description>
        <time_frame>3 Months Post Treatment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Group CBT</title>
            <description>Usual care + BRIGHT intervention. The BRIGHT intervention included 16 two-hour group sessions of CBT for depression.</description>
          </group>
          <group group_id="O2">
            <title>Comparison</title>
            <description>Usual care</description>
          </group>
        </group_list>
        <measure>
          <title>Depressive Symptoms as Measured by the Beck Depression Inventory II</title>
          <description>The Beck Depression Inventory II (BDI-II) is a 21 question, self-administered measure of depressive symptoms. Scores range from 0 - 63, with higher scores indicating more severe depressive symptoms.</description>
          <units>BDI-II score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="120"/>
                <count group_id="O2" value="140"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.83" spread="11.23"/>
                    <measurement group_id="O2" value="21.82" spread="12.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mental Health Functioning as Measured by SF-12 MCS.</title>
        <description>The SF-12 is a 12 question, self-administered measure of general health functioning. The SF-12 outputs a mental health summary score (MCS), which ranges from 0 to 100, with higher scores indicating better mental health functioning. MCS scores are standardized such that mean = 50 and SD = 10 in the general U.S. population.</description>
        <time_frame>3 Months Post Treatment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Group CBT</title>
            <description>Usual care + BRIGHT intervention. The BRIGHT intervention included 16 two-hour group sessions of CBT for depression.</description>
          </group>
          <group group_id="O2">
            <title>Comparison</title>
            <description>Usual care.</description>
          </group>
        </group_list>
        <measure>
          <title>Mental Health Functioning as Measured by SF-12 MCS.</title>
          <description>The SF-12 is a 12 question, self-administered measure of general health functioning. The SF-12 outputs a mental health summary score (MCS), which ranges from 0 to 100, with higher scores indicating better mental health functioning. MCS scores are standardized such that mean = 50 and SD = 10 in the general U.S. population.</description>
          <units>SF-12 score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="120"/>
                <count group_id="O2" value="140"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44.71" spread="11.34"/>
                    <measurement group_id="O2" value="38.44" spread="11.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Group CBT</title>
          <description>Clients received up to 16 sessions of group CBT for depression</description>
        </group>
        <group group_id="E2">
          <title>Comparison</title>
          <description>Treatment as Usual comparison condition</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="140"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="159"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="140"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="159"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Katherine Watkins</name_or_title>
      <organization>RAND Corporation</organization>
      <phone>(310) 393-0411 ext 6509</phone>
      <email>kwatkins@rand.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

